Back to company

BioLean ApS: Financial statements 2024

CVR: 41078219

BioLean ApS (CVR 41078219) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,287,303 and a net result of DKK 6,782 compared with DKK 132,126 the year before. That is a decrease of 50.8% compared with the year before. Equity amounted to DKK 366,250. The solvency ratio was 40%. The company had 3 employees in the financial year.

Gross Profit
1,287,303 kr.
Profit/Loss
6,782 kr.
Equity
366,250 kr.
Total Assets
916,392 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-1.3 mio.7 t.366 t.3
2023-2.6 mio.132 t.359 t.3
2022-1.6 mio.64 t.127 t.2
2021-1.8 mio.-212 t.64 t.4
2020-629 t.176 t.276 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BioLean ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

BioLean ApS appoints new auditorOct 21, 2024

As of October 21, 2024, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of BioLean ApS.

Auditor steps down at BioLean ApSOct 21, 2024

As of October 21, 2024, DP Hillerød P/S has stepped down as auditor of BioLean ApS.

BioLean ApS: The 2023 annual report is outMay 14, 2024

BioLean ApS has published its annual report for 2023. Gross profit came to DKK 2,616,548, and the net result was DKK 132,126.

About BioLean ApS

BioLean ApS is a Danish company of the type Anpartsselskab based in Gørlev, founded in 2020. The company is registered under the industry Computerprogrammering. The management consists of Jesper Bryde-Jacobsen, Laurent Jan Vermue and Maciej Jan Korzepa. The company's owners include Laurent Jan Vermue, Maciej Jan Korzepa and Tomasz Grzegorz Nowak. In 2025, the company reported a gross profit of DKK 1,226,619 and a net result of DKK -11,923 compared with DKK 6,782 the year before. Equity amounted to DKK 354,328.

Other financial years